Sort
15,440 grants matching “organoids”
MECHANISMS OF CHIEF CELL DEDIFFERENTIATION
$443,607Jason C Mills · Washington University · R01 · FY2019 · DK
Center for Functional Validation and Evaluation of ENCODE Enhancer Regions, Grant Number 5UM1HG009426-03
$443,573Jennifer Robin Moran · Tempus Labs, Inc. · UM1 · FY2020 · HG
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$443,556Xinna Zhang · Indiana University Indianapolis · R01 · FY2024 · CA
Mechanisms Governing Uterine Epithelial Plasticity
$443,436Andrew M Kelleher · University Of Missouri-Columbia · R01 · FY2025 · HD
Development of Complex Liver Organoids Using Cell-Specific Patterned Biomaterials
$443,432Muhammad Rizwan · Michigan Technological University · R15 · FY2023 · DK
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
$443,412Reuben J Shaw · Salk Institute For Biological Studies · P01 · FY2024 · CA
NRSA Training Core
$443,341Darrell N. Kotton · Boston University Medical Campus · TL1 · FY2021 · TR
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
$443,326Michael M. Shen · Columbia University Health Sciences · P01 · FY2025 · CA
In vivio single-cell analysis of dynamic cell behaviors
$443,265Anna-Katerina Hadjantonakis · Sloan-Kettering Inst Can Research · R01 · FY2025 · GM
Preclinical validation of oral therapeutic lead proteins targeting epithelial GM1 ganglioside for ulcerative colitis therapy
$443,196Nobuyuki Matoba · University Of Louisville · R01 · FY2022 · DK
High accuracy optical growth assay of 3D cellular systems
$443,191Gabriel Popescu · University Of Illinois At Urbana-Champaign · R01 · FY2019 · GM
Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents
$443,191Eun Hyun Ahn · Johns Hopkins University · R01 · FY2024 · CA
Blockade of cMYC oncogenic function by pregnancy-induced alterations and remodeling of the mammary gland
$443,162Camila Dos Santos · Cold Spring Harbor Laboratory · R01 · FY2024 · CA
iPSC-derived Neurovascular Organoids
$443,089Ethan Lippmann · Vanderbilt University · R01 · FY2024 · NS
Engineering induction and assembly of human kidney tissue
$443,066Alex Hughes · University Of Pennsylvania · R01 · FY2025 · DK
Genomic Editing & Screening
$443,017Ralph J. Garippa · Sloan-Kettering Inst Can Research · P30 · FY2024 · CA
Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer
$443,001Mark R. Kelley · Indiana University Indianapolis · R01 · FY2024 · CA
The impact of hiPSC-derived microglia in human brain development in health and disease
$442,942Alysson R. Muotri · University Of California, San Diego · R01 · FY2021 · NS
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease
$442,942Alysson R. Muotri · University Of California, San Diego · R01 · FY2025 · NS
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease
$442,942Alysson R. Muotri · University Of California, San Diego · R01 · FY2023 · NS
The Impact of hiPSC-Derived Microglia in Human Brain Development in Health and Disease
$442,942Alysson R. Muotri · University Of California, San Diego · R01 · FY2022 · NS
Therapeutic Targeting of WDR5 in the Glioblastoma Perivascular Niche
$442,887Christopher G Hubert · Case Western Reserve University · R01 · FY2024 · NS
3D Bioprinted Spinal Cord Organoids as a Relay System for Spinal Cord Injury
$442,883Ann M Parr · University Of Minnesota · R01 · FY2021 · NS
MECHANISMS OF CHIEF CELL DEDIFFERENTIATION
$442,795Jason C Mills · Baylor College Of Medicine · R01 · FY2021 · DK
In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer
$442,767Jennifer M. Rosenbluth · University Of California, San Francisco · R01 · FY2022 · CA